Community Healthcare Trust (CHCT)
NYSE:CHCT
Top Page
Community Healthcare
(NYSE:CHCT)
Select Model
Select Model
Rating:66Neutral
Price Target:
$19.50
â–²(16.91% Upside)
Action:ReiteratedDate:02/18/26
CHCT scores mid-range primarily due to steady revenue and strong, consistent cash generation alongside improved balance-sheet risk, but is held back by volatile/uncertain earnings reflected in a negative P/E. Technicals are supportive with price above key moving averages and positive MACD, and the earnings call was net constructive (FFO/AFFO growth, accretive transactions, dividend raise) despite tenant-transaction timing risk and constrained equity funding flexibility.
Positive Factors
Consistent cash generation
Sustained positive operating and free cash flow provides durable internal funding for dividends, redevelopment projects and acquisitions. This cash generation reduces reliance on external equity, supports liquidity and gives management flexibility to execute capital recycling and cover operating needs.
Negative Factors
Volatile earnings history
Significant swings in net income undermine confidence in earnings quality and make cash‑flow forecasting harder. This volatility complicates dividend coverage assessment and planning for acquisitions, increasing execution risk over the medium term despite underlying revenue growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent cash generation
Sustained positive operating and free cash flow provides durable internal funding for dividends, redevelopment projects and acquisitions. This cash generation reduces reliance on external equity, supports liquidity and gives management flexibility to execute capital recycling and cover operating needs.
Read all positive factors
Community Healthcare (CHCT) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$476.58M
Dividend Yield12.08%
Average Volume (3M)267.93K
Price to Earnings (P/E)86.4
Beta (1Y)0.74
Revenue Growth3.40%
EPS Growth-240.85%
CountryUS
Employees36
SectorReal Estate
Sector Strength53
IndustryREIT - Healthcare Facilities
Share Statistics
EPS (TTM)0.51
Shares Outstanding28,571,793
10 Day Avg. Volume143,465
30 Day Avg. Volume267,932
Financial Highlights & Ratios
PEG Ratio-0.65
Price to Book (P/B)1.03
Price to Sales (P/S)3.64
P/FCF Ratio7.81
Enterprise Value/Market Cap2.12
Enterprise Value/Revenue8.35
Enterprise Value/Gross Profit13.34
Enterprise Value/Ebitda13.04
Forecast
1Y Price Target
$18.50Price Target Upside10.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)0.47
Revenue Forecast (FY)$126.61M
Community Healthcare Business Overview & Revenue Model
Company Description
Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout ...
How the Company Makes Money
Community Healthcare generates revenue through multiple streams, primarily by billing for medical services provided to patients. This includes fees for consultations, treatments, and diagnostic services covered by private insurance, Medicare, and ...
Community Healthcare Earnings Call Summary
Earnings Call Date:Feb 17, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 05, 2026
Earnings Call Sentiment Positive
The call conveyed modest but clear operational and financial progress: revenue, FFO and AFFO showed year-over-year growth; capital recycling generated meaningful gains and funded accretive acquisitions; occupancy and lease-term metrics improved and dividend was raised. Key risks include timing uncertainty around the sale of the operator of six geriatric behavioral hospitals, short-term sequencing impacts from dispositions/acquisitions that slightly pressured quarter-over-quarter per-share metrics, and limited ability to raise equity at current prices. On balance, the positives (organic growth, accretive transactions, strengthened portfolio metrics, and disciplined capital recycling) outweigh the near-term execution and financing uncertainties.Positive Updates
Revenue Growth Year-over-Year
Total revenue increased from $29.3M in Q4 2024 to $30.9M in Q4 2025, representing 5.6% year-over-year growth.
Negative Updates
Quarter-over-Quarter Revenue and Per-Share Pressure
Total revenue declined slightly by $140,000 quarter-over-quarter (from $31.1M in Q3 2025 to $30.9M in Q4 2025). FFO and AFFO per diluted share were each down $0.01 quarter-over-quarter (FFO $0.50 -> $0.49; AFFO $0.56 -> $0.55).
Read all updates
Q4-2025 Updates
Positive
Negative
Revenue Growth Year-over-Year
Total revenue increased from $29.3M in Q4 2024 to $30.9M in Q4 2025, representing 5.6% year-over-year growth.
Read all positive updates
Company Guidance
Management guided that portfolio leased occupancy should remain in the low-90% range near the Q4 level of 90.6% (up from 90.1%), with weighted average lease term up to 7.0 years (from 6.7) and expected occupancy momentum in the second half of 2026; three redevelopment projects are underway (largest to complete in Q2 2026 with rent to commence in Q3 after licensing). On transactions and capital recycling, CHCT closed three acquisitions for the year (113,000 sq ft for $64.5M, 100% leased with leases through 2040 and expected returns of 9.3%–9.5%), sold an IRF at ~7.9% cap with an ~$11.5M gain and reinvested $28.5M via 1031 into a new IRF (new lease through 2040, ~9.3% return), recorded net gains on sales of $12.1M in Q4, had ~$7.7M of net proceeds from recent dispositions, signed PSAs for five properties with aggregate expected investment of $122.5M (expected returns 9.1%–9.75%; one closing Q1, two in 2H‑2026, two in 2H‑2027), did not issue shares on the ATM, expects to fund near‑term acquisitions with selected asset sales and revolver capacity while maintaining modest leverage and using 1031 exchanges when appropriate. Financial anchors reported as guidance context include Q4 total revenue $30.9M (5.6% YoY), FFO $13.3M ($0.49 diluted, +4.6% YoY), AFFO $14.9M ($0.55 diluted), property operating expense ~$6.0M, G&A $4.8M, interest expense ~$7.0M, and a raised Q4 dividend of $0.4775 ($1.91 annualized).Community Healthcare Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
56
Neutral
Cash Flow
68
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 121.19M | 115.79M | 112.84M | 97.68M | 90.58M |
| Gross Profit | 10.49M | 92.95M | 92.13M | 81.04M | 75.42M |
| EBITDA | 82.71M | 64.23M | 66.25M | 67.13M | 64.43M |
| Net Income | 5.10M | -3.18M | 7.71M | 22.02M | 22.49M |
Balance Sheet | |||||
| Total Assets | 990.76M | 992.56M | 945.41M | 876.42M | 754.23M |
| Cash, Cash Equivalents and Short-Term Investments | 3.34M | 4.38M | 3.49M | 11.23M | 2.35M |
| Total Debt | 536.20M | 489.98M | 412.28M | 357.06M | 269.39M |
| Total Liabilities | 561.37M | 516.60M | 432.16M | 379.61M | 292.12M |
| Stockholders Equity | 429.39M | 475.96M | 513.26M | 496.81M | 462.11M |
Cash Flow | |||||
| Free Cash Flow | 56.43M | 34.24M | 42.40M | 49.90M | 49.13M |
| Operating Cash Flow | 56.43M | 58.88M | 61.38M | 60.28M | 56.35M |
| Investing Cash Flow | -47.70M | -92.66M | -113.67M | -113.77M | -104.43M |
| Financing Cash Flow | -9.78M | 33.53M | 44.86M | 62.69M | 48.05M |
Community Healthcare Technical Analysis
Positive
16.68
Price Trends
16.62
Positive
16.04
Positive
15.16
Positive
Market Momentum
-0.10
Negative
57.55
Neutral
88.30
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CHCT, the sentiment is Positive. The current price of 16.68 is above the 20-day moving average (MA) of 16.08, above the 50-day MA of 16.62, and above the 200-day MA of 15.16, indicating a bullish trend. The MACD of -0.10 indicates Negative momentum. The RSI at 57.55 is Neutral, neither overbought nor oversold. The STOCH value of 88.30 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CHCT.
Community Healthcare Risk Analysis
Community Healthcare disclosed 85 risk factors in its most recent earnings report. Community Healthcare reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Community Healthcare Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.34B | 38.71 | 2.44% | 6.98% | 3.74% | 77.82% | |
66 Neutral | $476.58M | 86.44 | 1.16% | 12.08% | 3.40% | -240.85% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | $584.40M | 30.78 | 10.87% | 7.51% | 0.68% | -1.34% | |
64 Neutral | $171.91M | 21.52 | 49.30% | 4.62% | 29.76% | 22.76% | |
54 Neutral | $1.70B | -4.08 | -15.98% | 0.80% | 4.10% | 8.96% |
* Real Estate Sector Average
CHCT
Community Healthcare
16.68
2.13
14.62%
DHC
Diversified Healthcare Trust
7.03
4.72
203.93%
UHT
Universal Health Realty Income
42.12
6.99
19.91%
STRW
Strawberry Fields REIT Inc
12.85
2.48
23.95%
SILA
Sila Realty Trust, Inc.
24.22
-0.19
-0.79%
Community Healthcare Corporate Events
Business Operations and StrategyDividendsFinancial Disclosures
Community Healthcare Trust Announces Dividend and Q4 Results
Positive
Feb 17, 2026
Community Healthcare Trust reported net income of about $14.4 million, or $0.51 per diluted share, for the quarter ended December 31, 2025, with FFO and AFFO of $0.49 and $0.55 per diluted share, respectively. The company’s board also declar...
Business Operations and Strategy
Community Healthcare Expands Equity-Based Alignment of Interest Program
Positive
Jan 9, 2026
On January 5, 2026, Community Healthcare Trust Incorporated’s Board of Directors approved a Second Amendment to its Fourth Amended and Restated Alignment of Interest Program, increasing the pool by 500,000 restricted common shares. These add...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.